Patent 11987602 was granted and assigned to CB Therapeutics on May, 2024 by the United States Patent and Trademark Office.
The methods and systems disclose enzymes that function to import malonic acid or malonates into a cell. The enzymes increase the output of precursor molecules by enriching certain pathways in the cell. The precursor molecules can be converted to cannabinoids. The enzymes are a family of proteins which have a majority of common alignments.